PIPERACILLIN SODIUM,TAZOBACTAM SODIUM

PIPERACILLIN SODIUM,TAZOBACTAM SODIUM was reported 27275 times

PIPERACILLIN SODIUM,TAZOBACTAM SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI FACTOR V ANTIBODY 20 0.7143
1 NEW ONSET REFRACTORY STATUS EPILEPTICUS 27 0.2455
2 PROTOTHECOSIS 21 0.2234
3 RETINITIS VIRAL 20 0.1653
4 CHOROIDITIS 55 0.1471
5 INTRA-ABDOMINAL PRESSURE INCREASED 20 0.1274
6 TRICHOSPORON INFECTION 50 0.1235
7 GEOTRICHUM INFECTION 26 0.1232
8 DELUSION OF GRANDEUR 50 0.1114
9 AEROMONAS INFECTION 17 0.0899
10 CLOSTRIDIUM TEST POSITIVE 197 0.0893
11 SPINAL MUSCULAR ATROPHY 24 0.0889
12 ALVEOLAR LUNG DISEASE 16 0.0842
13 PYROGLUTAMIC ACIDOSIS 33 0.0831
14 RHINOCEREBRAL MUCORMYCOSIS 28 0.0807
15 LINEAR IGA DISEASE 132 0.0793
16 RESPIRATORY TRACT INFECTION BACTERIAL 37 0.0743
17 ANAL INFLAMMATION 47 0.0736
18 DISSEMINATED MUCORMYCOSIS 28 0.0711
19 TRICHOGLOSSIA 29 0.0707
20 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 25 0.0658
21 DYSBIOSIS 54 0.0658
22 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 53 0.0645
23 CONGENITAL APLASIA 20 0.0643
24 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 25 0.0616
25 PULMONARY MUCORMYCOSIS 32 0.0606
26 SYSTEMIC CANDIDA 146 0.0581
27 NECROSIS ISCHAEMIC 26 0.0564
28 STOMA CLOSURE 17 0.0547
29 ABDOMINAL COMPARTMENT SYNDROME 34 0.0534
30 SARS-COV-2 TEST NEGATIVE 35 0.0519
31 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 16 0.0518
32 PNEUMATOSIS 23 0.0516
33 CONGESTIVE HEPATOPATHY 21 0.0469
34 PSEUDOMONAL BACTERAEMIA 40 0.0468
35 FUNGAEMIA 73 0.0463
36 ENTEROCOCCUS TEST POSITIVE 30 0.0463
37 ENDOMETRIAL DISORDER 19 0.0460
38 PNEUMOCOCCAL SEPSIS 30 0.0457
39 SJS-TEN OVERLAP 31 0.0442
40 TUMOUR ASSOCIATED FEVER 18 0.0440
41 LYMPHOCYTE COUNT ABNORMAL 49 0.0435
42 PNEUMONIA NECROTISING 28 0.0433
43 BILIARY SEPSIS 20 0.0432
44 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 22 0.0431
45 MOTOR NEURONE DISEASE 20 0.0411
46 SERRATIA INFECTION 30 0.0403
47 APLASTIC ANAEMIA 209 0.0400
48 CITROBACTER INFECTION 17 0.0396
49 FUSARIUM INFECTION 27 0.0386
50 DIFFERENTIATION SYNDROME 28 0.0381
51 RESPIRATORY TRACT INFECTION FUNGAL 20 0.0379
52 ACINETOBACTER INFECTION 41 0.0374
53 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 960 0.0373
54 PSOAS ABSCESS 23 0.0369
55 MUCORMYCOSIS 96 0.0369
56 JARISCH-HERXHEIMER REACTION 26 0.0365
57 DISSEMINATED ASPERGILLOSIS 17 0.0360
58 EOSINOPHILIC PNEUMONIA ACUTE 31 0.0358
59 URINARY TRACT INFECTION ENTEROCOCCAL 33 0.0353
60 RASH MORBILLIFORM 97 0.0350
61 PROCALCITONIN INCREASED 41 0.0349
62 URINARY TRACT DISCOMFORT 16 0.0347
63 MEGACOLON 53 0.0337
64 STRONGYLOIDIASIS 54 0.0334
65 BLAST CELLS PRESENT 16 0.0333
66 CLOSTRIDIUM DIFFICILE COLITIS 346 0.0326
67 SCEDOSPORIUM INFECTION 23 0.0326
68 DELAYED GRAFT FUNCTION 23 0.0323
69 TOXIC EPIDERMAL NECROLYSIS 476 0.0313
70 LARGE INTESTINE INFECTION 38 0.0309
71 PATHOGEN RESISTANCE 281 0.0308
72 KOUNIS SYNDROME 70 0.0308
73 CANDIDA SEPSIS 27 0.0301
74 ASPERGILLUS INFECTION 197 0.0300
75 CORYNEBACTERIUM INFECTION 16 0.0299
76 PSEUDOMEMBRANOUS COLITIS 66 0.0295
77 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 226 0.0291
78 ENTEROCOCCAL INFECTION 139 0.0287
79 MIXED LIVER INJURY 86 0.0286
80 BRONCHOPULMONARY ASPERGILLOSIS 221 0.0285
81 ENTEROCOCCAL SEPSIS 23 0.0284
82 PNEUMONIA PSEUDOMONAL 43 0.0280
83 HEPATIC CYTOLYSIS 356 0.0279
84 COAGULATION TEST ABNORMAL 21 0.0273
85 EOSINOPHILIA 473 0.0270
86 MULTIPLE ORGAN DYSFUNCTION SYNDROME 725 0.0256
87 BACILLUS INFECTION 16 0.0253
88 FUNGAL SEPSIS 21 0.0253
89 DIFFUSE ALVEOLAR DAMAGE 29 0.0252
90 NEUTROPENIC COLITIS 52 0.0251
91 FOLATE DEFICIENCY 29 0.0251
92 HAEMOPERITONEUM 20 0.0250
93 RASH MACULO-PAPULAR 555 0.0249
94 PERFORATION 20 0.0248
95 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 186 0.0248
96 TRACHEOBRONCHITIS 19 0.0247
97 RENAL TUBULAR NECROSIS 237 0.0241
98 SUPERINFECTION BACTERIAL 19 0.0240
99 CHOLESTATIC LIVER INJURY 53 0.0238
100 LUNG CONSOLIDATION 66 0.0236
101 TUMOUR FLARE 16 0.0234
102 KLEBSIELLA INFECTION 118 0.0233
103 MYOPERICARDITIS 18 0.0231
104 PULMONARY NOCARDIOSIS 19 0.0231
105 NEUTROPENIC INFECTION 22 0.0230
106 FEBRILE INFECTION 27 0.0229
107 STENOTROPHOMONAS INFECTION 31 0.0228
108 DIARRHOEA INFECTIOUS 18 0.0228
109 ISCHAEMIC CEREBRAL INFARCTION 26 0.0224
110 PNEUMONIA KLEBSIELLA 41 0.0223
111 KLEBSIELLA SEPSIS 25 0.0222
112 STREPTOCOCCAL BACTERAEMIA 24 0.0221
113 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 24 0.0218
114 CHOLESTASIS 416 0.0216
115 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 20 0.0216
116 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 20 0.0216
117 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 82 0.0214
118 SYSTEMIC MYCOSIS 25 0.0214
119 FEBRILE BONE MARROW APLASIA 89 0.0209
120 INFECTIOUS PLEURAL EFFUSION 31 0.0204
121 STAPHYLOCOCCAL BACTERAEMIA 87 0.0200
122 MULTIPLE-DRUG RESISTANCE 62 0.0200
123 PSEUDOMONAL SEPSIS 35 0.0200
124 PERIPHERAL SENSORIMOTOR NEUROPATHY 25 0.0199
125 RENAL TUBULAR DISORDER 56 0.0199
126 PSEUDOMONAS INFECTION 168 0.0196
127 PSEUDOMONAS TEST POSITIVE 16 0.0195
128 PNEUMOMEDIASTINUM 35 0.0193
129 TOXIC SKIN ERUPTION 195 0.0193
130 ANAEMIA HAEMOLYTIC AUTOIMMUNE 16 0.0193
131 NEPHROPATHY TOXIC 216 0.0192
132 PNEUMONIA FUNGAL 75 0.0190
133 MENINGITIS CRYPTOCOCCAL 33 0.0189
134 LUNG HYPERINFLATION 16 0.0186
135 ENTEROBACTER INFECTION 31 0.0184
136 SEPTIC SHOCK 802 0.0184
137 EOSINOPHILIC PNEUMONIA 58 0.0184
138 DRUG CLEARANCE DECREASED 24 0.0184
139 CYTOMEGALOVIRUS INFECTION REACTIVATION 81 0.0183
140 NECROTISING COLITIS 23 0.0181
141 PLATELET TRANSFUSION 23 0.0179
142 TUBULOINTERSTITIAL NEPHRITIS 334 0.0178
143 HEPATITIS CHOLESTATIC 107 0.0177
144 CROSS SENSITIVITY REACTION 17 0.0175
145 LYMPHADENECTOMY 17 0.0174
146 APLASIA 34 0.0173
147 VASCULAR PURPURA 24 0.0172
148 VANISHING BILE DUCT SYNDROME 19 0.0170
149 VASCULAR DEVICE INFECTION 77 0.0170
150 HAEMATOLOGICAL INFECTION 41 0.0167
151 CUTANEOUS VASCULITIS 61 0.0167
152 ACUTE RESPIRATORY DISTRESS SYNDROME 294 0.0166
153 DIABETES INSIPIDUS 40 0.0166
154 IMMUNE THROMBOCYTOPENIA 76 0.0166
155 PULMONARY SEPSIS 24 0.0165
156 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 35 0.0164
157 ESCHERICHIA INFECTION 134 0.0163
158 HYPERNATRAEMIA 81 0.0162
159 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 96 0.0162
160 LUNG ABSCESS 34 0.0162
161 HAEMODYNAMIC INSTABILITY 123 0.0161
162 CELL DEATH 32 0.0161
163 STAPHYLOCOCCUS TEST POSITIVE 34 0.0161
164 AGRANULOCYTOSIS 294 0.0158
165 CYTOKINE RELEASE SYNDROME 316 0.0157
166 ESCHERICHIA BACTERAEMIA 37 0.0157
167 INFECTION REACTIVATION 18 0.0157
168 RESUSCITATION 26 0.0157
169 TYPE IV HYPERSENSITIVITY REACTION 42 0.0153
170 RHINALGIA 42 0.0153
171 LIVER ABSCESS 49 0.0151
172 EMPYEMA 30 0.0151
173 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 18 0.0150
174 INCREASED BRONCHIAL SECRETION 38 0.0148
175 NEUTROPENIC SEPSIS 106 0.0148
176 PELVIC ABSCESS 17 0.0148
177 HYPERLACTACIDAEMIA 39 0.0145
178 HYPERTRANSAMINASAEMIA 101 0.0145
179 OLIGURIA 90 0.0145
180 INTESTINAL ISCHAEMIA 79 0.0143
181 SPUTUM INCREASED 31 0.0143
182 AUTOIMMUNE HAEMOLYTIC ANAEMIA 49 0.0143
183 PNEUMOCYSTIS JIROVECII INFECTION 17 0.0142
184 RESPIRATORY ALKALOSIS 23 0.0141
185 CRYPTOCOCCOSIS 23 0.0141
186 RENAL TUBULAR INJURY 17 0.0140
187 VENOOCCLUSIVE DISEASE 35 0.0140
188 VENOOCCLUSIVE LIVER DISEASE 69 0.0140
189 CLOSTRIDIUM DIFFICILE INFECTION 302 0.0138
190 BACTERAEMIA 164 0.0138
191 BACTERIAL SEPSIS 45 0.0138
192 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 38 0.0137
193 METABOLIC ALKALOSIS 22 0.0137
194 HYPERBILIRUBINAEMIA 142 0.0137
195 ACUTE KIDNEY INJURY 2093 0.0137
196 LUNG OPACITY 36 0.0136
197 SOFT TISSUE INFECTION 25 0.0136
198 BRONCHIAL DISORDER 21 0.0135
199 CANDIDA INFECTION 228 0.0135
200 FEBRILE NEUTROPENIA 895 0.0135
201 HISTOPLASMOSIS DISSEMINATED 21 0.0132
202 MECHANICAL VENTILATION 25 0.0131
203 CAPILLARY LEAK SYNDROME 27 0.0130
204 VARICELLA ZOSTER VIRUS INFECTION 27 0.0130
205 RESPIRATORY ACIDOSIS 51 0.0130
206 METHAEMOGLOBINAEMIA 30 0.0129
207 HYPERTROPHIC CARDIOMYOPATHY 20 0.0129
208 NEPHRITIS 43 0.0129
209 HEPATITIS FULMINANT 38 0.0128
210 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 34 0.0128
211 CHEST X-RAY ABNORMAL 39 0.0127
212 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 41 0.0126
213 LEUKOCYTOSIS 226 0.0125
214 DRUG RESISTANCE 319 0.0124
215 CLOSTRIDIAL INFECTION 42 0.0124
216 CYTOMEGALOVIRUS TEST POSITIVE 22 0.0123
217 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 61 0.0122
218 TACHYPNOEA 166 0.0122
219 EXCESSIVE EYE BLINKING 18 0.0122
220 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 28 0.0120
221 LOSS OF EMPLOYMENT 36 0.0119
222 PNEUMOPERITONEUM 22 0.0119
223 PNEUMONIA LEGIONELLA 19 0.0119
224 PNEUMONIA CYTOMEGALOVIRAL 23 0.0118
225 BLOOD PRESSURE DIASTOLIC ABNORMAL 30 0.0118
226 BICYTOPENIA 23 0.0117
227 INTRA-ABDOMINAL FLUID COLLECTION 21 0.0117
228 CALCULUS URINARY 18 0.0117
229 INFLAMMATORY MARKER INCREASED 58 0.0117
230 PNEUMOCYSTIS JIROVECII PNEUMONIA 117 0.0116
231 MYELOPATHY 22 0.0116
232 MUCOSAL INFLAMMATION 298 0.0114
233 SHOCK HAEMORRHAGIC 92 0.0113
234 CYTOMEGALOVIRUS INFECTION 187 0.0112
235 DERMATITIS EXFOLIATIVE GENERALISED 39 0.0112
236 HYPOALBUMINAEMIA 87 0.0112
237 DRUG LEVEL INCREASED 184 0.0111
238 VASOPLEGIA SYNDROME 18 0.0110
239 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 36 0.0109
240 GRAFT VERSUS HOST DISEASE IN SKIN 24 0.0109
241 PYELONEPHRITIS ACUTE 21 0.0107
242 STEVENS-JOHNSON SYNDROME 238 0.0107
243 GASTROINTESTINAL WALL THICKENING 16 0.0107
244 TUMOUR LYSIS SYNDROME 94 0.0107
245 COVID-19 PNEUMONIA 126 0.0107
246 ENDOPHTHALMITIS 64 0.0107
247 HEPATOCELLULAR INJURY 151 0.0106
248 HYPERAMMONAEMIA 53 0.0106
249 PNEUMATOSIS INTESTINALIS 30 0.0105
250 ENCEPHALOPATHY 258 0.0105
251 NOSOCOMIAL INFECTION 23 0.0104
252 DEVICE RELATED SEPSIS 21 0.0104
253 SUSPECTED OFF LABEL USE 47 0.0104
254 HEPATIC NECROSIS 39 0.0103
255 HYPERTHERMIA 79 0.0103
256 OTOTOXICITY 19 0.0103
257 TOXIC ENCEPHALOPATHY 52 0.0103
258 DISSEMINATED INTRAVASCULAR COAGULATION 144 0.0102
259 RETROPERITONEAL HAEMORRHAGE 25 0.0101
260 PUSTULE 24 0.0101
261 LIVEDO RETICULARIS 21 0.0100
262 ENDOTRACHEAL INTUBATION 28 0.0100
263 THROMBOCYTOSIS 36 0.0098
264 EOSINOPHIL COUNT INCREASED 81 0.0097
265 PANCYTOPENIA 541 0.0097
266 RESPIRATORY FAILURE 705 0.0097
267 JAUNDICE CHOLESTATIC 34 0.0096
268 THROMBOCYTOPENIA 1046 0.0093
269 ESCHERICHIA SEPSIS 27 0.0093
270 ADENOVIRUS INFECTION 27 0.0093
271 OPPORTUNISTIC INFECTION 17 0.0092
272 EXTREMITY NECROSIS 16 0.0092
273 PNEUMONIA BACTERIAL 84 0.0091
274 DRUG ERUPTION 162 0.0091
275 CYTOMEGALOVIRUS COLITIS 21 0.0091
276 ANURIA 78 0.0091
277 ACUTE RESPIRATORY FAILURE 174 0.0090
278 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 86 0.0090
279 METABOLIC ENCEPHALOPATHY 27 0.0090
280 GLOMERULONEPHRITIS 22 0.0090
281 HYPOVOLAEMIC SHOCK 43 0.0090
282 LUNG INFILTRATION 79 0.0089
283 ACUTE HEPATIC FAILURE 122 0.0089
284 PROCTALGIA 57 0.0089
285 TRANSPLANT REJECTION 71 0.0089
286 COMPLICATIONS OF TRANSPLANTED KIDNEY 20 0.0088
287 INTRA-ABDOMINAL HAEMORRHAGE 21 0.0088
288 NECROTISING FASCIITIS 31 0.0088
289 LARGE INTESTINE PERFORATION 61 0.0088
290 IMMUNE-MEDIATED LUNG DISEASE 16 0.0088
291 CLONUS 24 0.0088
292 CHOLANGITIS 54 0.0087
293 DRUG-INDUCED LIVER INJURY 273 0.0087
294 LYMPHOCYTE COUNT DECREASED 152 0.0086
295 NEUTROPHIL COUNT INCREASED 88 0.0086
296 PULMONARY ALVEOLAR HAEMORRHAGE 48 0.0085
297 TUNNEL VISION 16 0.0085
298 ARTERIOSPASM CORONARY 34 0.0085
299 HUMAN HERPESVIRUS 6 INFECTION 16 0.0085
300 HYPOPROTEINAEMIA 16 0.0084
301 LEUKOPENIA 421 0.0084
302 DISTRIBUTIVE SHOCK 19 0.0084
303 ACUTE MYELOID LEUKAEMIA RECURRENT 18 0.0084
304 HAEMOLYTIC ANAEMIA 75 0.0084
305 OXYGEN CONSUMPTION INCREASED 20 0.0084
306 CIRCULATORY COLLAPSE 142 0.0083
307 PERICARDIAL HAEMORRHAGE 18 0.0082
308 MYCOBACTERIUM AVIUM COMPLEX INFECTION 22 0.0082
309 DISSEMINATED TUBERCULOSIS 21 0.0082
310 RETROPERITONEAL HAEMATOMA 18 0.0081
311 UROSEPSIS 75 0.0081
312 STAPHYLOCOCCAL SEPSIS 40 0.0081
313 HYPERVOLAEMIA 40 0.0081
314 DISEASE COMPLICATION 37 0.0081
315 BRAIN HERNIATION 24 0.0080
316 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 437 0.0080
317 LONG QT SYNDROME 19 0.0079
318 HEPARIN-INDUCED THROMBOCYTOPENIA 39 0.0079
319 BRAIN ABSCESS 20 0.0079
320 HYPOXIA 278 0.0079
321 ATELECTASIS 76 0.0079
322 DRUG LEVEL ABOVE THERAPEUTIC 36 0.0079
323 STRIDOR 23 0.0078
324 DIVERTICULAR PERFORATION 16 0.0078
325 CEREBELLAR SYNDROME 17 0.0078
326 ODYNOPHAGIA 46 0.0077
327 ABDOMINAL ABSCESS 34 0.0077
328 BLOOD IMMUNOGLOBULIN G DECREASED 19 0.0077
329 HYPERCAPNIA 23 0.0076
330 CEREBRAL ISCHAEMIA 39 0.0076
331 HEPATIC FAILURE 228 0.0076
332 SERUM SICKNESS 21 0.0075
333 PURPURA 66 0.0075
334 CEREBRAL HAEMATOMA 25 0.0074
335 NOCARDIOSIS 19 0.0074
336 HISTIOCYTOSIS HAEMATOPHAGIC 22 0.0074
337 SERUM FERRITIN INCREASED 39 0.0074
338 RENAL TUBULAR ACIDOSIS 16 0.0073
339 SINUS PAIN 17 0.0073
340 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 18 0.0073
341 GENERALISED OEDEMA 90 0.0073
342 COAGULOPATHY 121 0.0073
343 SHOCK 167 0.0073
344 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 16 0.0072
345 BLOOD CREATINE INCREASED 32 0.0072
346 HEPATOMEGALY 71 0.0072
347 GASTROINTESTINAL NECROSIS 21 0.0072
348 UPPER GASTROINTESTINAL HAEMORRHAGE 120 0.0071
349 NEUTROPENIA 968 0.0071
350 WHITE BLOOD CELL DISORDER 19 0.0071
351 SEPSIS 792 0.0071
352 DUODENAL ULCER 50 0.0071
353 METABOLIC ACIDOSIS 226 0.0071
354 NEONATAL RESPIRATORY DISTRESS SYNDROME 25 0.0071
355 HEPATOTOXICITY 157 0.0070
356 ENDOCARDITIS 36 0.0070
357 RESPIRATORY DISTRESS 193 0.0070
358 PNEUMONITIS 190 0.0070
359 APLASIA PURE RED CELL 24 0.0070
360 PULSELESS ELECTRICAL ACTIVITY 29 0.0069
361 PETECHIAE 72 0.0069
362 TORSADE DE POINTES 54 0.0069
363 RESPIRATORY TRACT INFECTION VIRAL 16 0.0069
364 AFFECTIVE DISORDER 54 0.0069
365 BONE MARROW FAILURE 138 0.0068
366 STAPHYLOCOCCAL INFECTION 224 0.0068
367 ACUTE PULMONARY OEDEMA 38 0.0068
368 HEPATITIS 173 0.0068
369 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 34 0.0067
370 WOUND COMPLICATION 23 0.0067
371 RHINOVIRUS INFECTION 26 0.0067
372 C-REACTIVE PROTEIN INCREASED 243 0.0067
373 ILEOSTOMY 17 0.0067
374 LYMPHOPENIA 94 0.0066
375 LARGE INTESTINAL ULCER 18 0.0066
376 NEUROTOXICITY 116 0.0066
377 LIVER INJURY 162 0.0066
378 PYELONEPHRITIS 57 0.0066
379 THROMBOTIC MICROANGIOPATHY 64 0.0066
380 HYPOKALAEMIA 303 0.0066
381 PNEUMOTHORAX 104 0.0066
382 RALES 38 0.0065
383 ASCITES 192 0.0065
384 TENOSYNOVITIS 18 0.0065
385 RASH PUSTULAR 47 0.0064
386 ENTEROCOLITIS 37 0.0064
387 GRAFT VERSUS HOST DISEASE 46 0.0064
388 CREPITATIONS 19 0.0064
389 HYPERPYREXIA 27 0.0064
390 METABOLIC DISORDER 37 0.0064
391 ACUTE GRAFT VERSUS HOST DISEASE 29 0.0063
392 ARTHRITIS BACTERIAL 26 0.0063
393 HYPERURICAEMIA 26 0.0063
394 CYTOLYTIC HEPATITIS 21 0.0063
395 PNEUMONIA ASPIRATION 158 0.0063
396 ILEUS PARALYTIC 28 0.0063
397 ABSCESS 100 0.0063
398 BLOOD LACTIC ACID INCREASED 33 0.0063
399 PARADOXICAL DRUG REACTION 23 0.0062
400 HEPATIC CYST 21 0.0062
401 HAEMORRHAGIC DIATHESIS 22 0.0062
402 FIBROSIS 19 0.0062
403 ACIDOSIS 47 0.0061
404 PULMONARY HAEMORRHAGE 48 0.0061
405 STATUS EPILEPTICUS 69 0.0061
406 PULMONARY TOXICITY 43 0.0061
407 RED CELL DISTRIBUTION WIDTH INCREASED 25 0.0060
408 ANAPHYLACTIC SHOCK 155 0.0060
409 GUILLAIN-BARRE SYNDROME 29 0.0060
410 NORMOCHROMIC NORMOCYTIC ANAEMIA 18 0.0060
411 OXYGEN SATURATION ABNORMAL 17 0.0060
412 DEVICE RELATED INFECTION 91 0.0059
413 EAR CONGESTION 16 0.0059
414 BACTERIAL INFECTION 110 0.0059
415 HYDRONEPHROSIS 44 0.0059
416 DEMYELINATION 24 0.0059
417 ACUTE MYELOID LEUKAEMIA 91 0.0058
418 BLOOD BILIRUBIN INCREASED 157 0.0058
419 DERMATITIS EXFOLIATIVE 29 0.0058
420 LOW BIRTH WEIGHT BABY 46 0.0058
421 MYOPATHY 50 0.0058
422 ERYSIPELAS 29 0.0058
423 MICTURITION DISORDER 20 0.0058
424 PLEURAL EFFUSION 351 0.0058
425 GAMMA-GLUTAMYLTRANSFERASE INCREASED 127 0.0057
426 CARDIAC FAILURE ACUTE 38 0.0057
427 HAEMOLYSIS 44 0.0057
428 CARDIAC TAMPONADE 27 0.0057
429 DELIRIUM 197 0.0057
430 POLYMYALGIA RHEUMATICA 18 0.0057
431 THYROIDITIS 17 0.0057
432 ORGANISING PNEUMONIA 28 0.0056
433 FORCED EXPIRATORY VOLUME DECREASED 16 0.0056
434 ABDOMINAL TENDERNESS 28 0.0056
435 KIDNEY TRANSPLANT REJECTION 27 0.0056
436 FIBRIN D DIMER INCREASED 20 0.0056
437 LEFT VENTRICULAR HYPERTROPHY 24 0.0056
438 SKIN NECROSIS 29 0.0056
439 PREMATURE DELIVERY 89 0.0056
440 SKIN EROSION 18 0.0056
441 MYELOSUPPRESSION 199 0.0055
442 HYPOVENTILATION 18 0.0055
443 CARDIOTOXICITY 49 0.0055
444 BRONCHIECTASIS 37 0.0055
445 CHOLECYSTITIS ACUTE 31 0.0055
446 CACHEXIA 28 0.0054
447 BODY TEMPERATURE INCREASED 111 0.0054
448 ELECTROLYTE IMBALANCE 63 0.0054
449 SEROTONIN SYNDROME 104 0.0054
450 ESCHERICHIA URINARY TRACT INFECTION 23 0.0054
451 CYTOMEGALOVIRUS VIRAEMIA 24 0.0054
452 ARTHRITIS INFECTIVE 25 0.0054
453 MYOCLONUS 64 0.0054
454 BLADDER PAIN 17 0.0053
455 BLOOD CULTURE POSITIVE 16 0.0053
456 LACTIC ACIDOSIS 171 0.0053
457 RHABDOMYOLYSIS 220 0.0053
458 OESOPHAGEAL CANDIDIASIS 21 0.0053
459 INTERSTITIAL LUNG DISEASE 254 0.0052
460 DRUG INTERACTION 831 0.0052
461 ISCHAEMIA 24 0.0052
462 CYSTITIS HAEMORRHAGIC 21 0.0052
463 BLOOD CREATININE INCREASED 339 0.0052
464 BRAIN NATRIURETIC PEPTIDE INCREASED 16 0.0052
465 BRAIN DEATH 16 0.0052
466 TRANSAMINASES INCREASED 115 0.0052
467 HYPOPHOSPHATAEMIA 38 0.0051
468 WOUND SECRETION 20 0.0051
469 CARDIOGENIC SHOCK 73 0.0051
470 INTESTINAL PERFORATION 57 0.0051
471 PYREXIA 1757 0.0051
472 HERPES SIMPLEX 33 0.0051
473 HEPATIC FUNCTION ABNORMAL 189 0.0051
474 CYTOPENIA 62 0.0051
475 BK VIRUS INFECTION 17 0.0050
476 COLITIS ISCHAEMIC 34 0.0050
477 HAEMODIALYSIS 42 0.0050
478 BLOOD ALKALINE PHOSPHATASE INCREASED 123 0.0049
479 BLOOD LACTATE DEHYDROGENASE INCREASED 78 0.0049
480 ILEUS 61 0.0049
481 OESOPHAGITIS 53 0.0048
482 DERMATITIS BULLOUS 35 0.0048
483 EPSTEIN-BARR VIRUS INFECTION 30 0.0048
484 BLOOD ALBUMIN DECREASED 38 0.0048
485 ADRENAL INSUFFICIENCY 58 0.0048
486 IMMUNOSUPPRESSION 42 0.0048
487 ELECTROCARDIOGRAM QT PROLONGED 171 0.0047
488 HYPOGAMMAGLOBULINAEMIA 31 0.0047
489 DRUG LEVEL BELOW THERAPEUTIC 26 0.0047
490 NEUTROPHIL COUNT DECREASED 191 0.0047
491 TRANSFUSION 49 0.0047
492 HYPERKALAEMIA 163 0.0046
493 CELLULITIS 231 0.0046
494 LEUKOENCEPHALOPATHY 17 0.0046
495 SINUS TACHYCARDIA 64 0.0045
496 JAUNDICE 121 0.0045
497 PARANASAL SINUS DISCOMFORT 17 0.0045
498 ORAL CANDIDIASIS 59 0.0045
499 RENAL IMPAIRMENT 376 0.0045
500 COLITIS 169 0.0045
501 SCHIZOPHRENIA 54 0.0044
502 HAEMATURIA 152 0.0044
503 UVEITIS 60 0.0044
504 PERIPHERAL ISCHAEMIA 18 0.0044
505 HALLUCINATION, AUDITORY 70 0.0044
506 ERYTHEMA MULTIFORME 41 0.0044
507 SARS-COV-2 TEST POSITIVE 58 0.0044
508 ALANINE AMINOTRANSFERASE INCREASED 269 0.0044
509 HYPOMAGNESAEMIA 61 0.0044
510 PROTHROMBIN TIME PROLONGED 26 0.0043
511 RASH VESICULAR 21 0.0043
512 NECROSIS 24 0.0043
513 HEPATITIS ACUTE 28 0.0043
514 LIPASE INCREASED 33 0.0043
515 BRAIN OEDEMA 54 0.0043
516 BENIGN PROSTATIC HYPERPLASIA 22 0.0043
517 HEPATIC ENCEPHALOPATHY 39 0.0042
518 ANAPHYLACTIC REACTION 230 0.0042
519 OCULAR ICTERUS 18 0.0041
520 DYSPHORIA 21 0.0041
521 LIVER FUNCTION TEST ABNORMAL 120 0.0041
522 SUBARACHNOID HAEMORRHAGE 42 0.0041
523 MALNUTRITION 46 0.0041
524 SPLENOMEGALY 48 0.0041
525 BRAIN INJURY 41 0.0041
526 ENTERITIS 26 0.0041
527 RESPIRATORY RATE INCREASED 36 0.0041
528 GENERALISED TONIC-CLONIC SEIZURE 67 0.0040
529 DRUG LEVEL DECREASED 41 0.0040
530 HEPATIC STEATOSIS 75 0.0040
531 PERITONITIS 83 0.0040
532 RASH ERYTHEMATOUS 190 0.0040
533 ORGAN FAILURE 16 0.0040
534 ASPARTATE AMINOTRANSFERASE INCREASED 210 0.0039
535 HYPOTHERMIA 40 0.0039
536 HAEMOPTYSIS 110 0.0039
537 PLATELET COUNT DECREASED 417 0.0039
538 ENCEPHALITIS 27 0.0039
539 CARDIAC ARREST 320 0.0039
540 SCOLIOSIS 24 0.0039
541 PAPULE 27 0.0038
542 MULTI-ORGAN FAILURE 66 0.0038
543 PULSE ABSENT 18 0.0038
544 THERAPY NON-RESPONDER 170 0.0038
545 LIP OEDEMA 16 0.0038
546 OBSTRUCTIVE AIRWAYS DISORDER 42 0.0038
547 HEPATIC PAIN 16 0.0037
548 CONDITION AGGRAVATED 1136 0.0037
549 SKIN TOXICITY 21 0.0037
550 ANAL ABSCESS 20 0.0037
551 HYPOTENSION 741 0.0037
552 MELAENA 81 0.0037
553 EJECTION FRACTION DECREASED 57 0.0037
554 LOWER GASTROINTESTINAL HAEMORRHAGE 27 0.0036
555 NEPHROPATHY 34 0.0036
556 APPENDICITIS 34 0.0036
557 SKIN WARM 21 0.0036
558 PERIPHERAL SENSORY NEUROPATHY 21 0.0036
559 HYPOVOLAEMIA 21 0.0036
560 ATRIOVENTRICULAR BLOCK COMPLETE 24 0.0036
561 FACE OEDEMA 60 0.0036
562 HYPOCALCAEMIA 67 0.0035
563 INTRAOCULAR PRESSURE INCREASED 45 0.0035
564 ACCIDENT 42 0.0035
565 NEUTROPHILIA 20 0.0035
566 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 31 0.0035
567 HYDROCEPHALUS 19 0.0035
568 TACHYCARDIA 309 0.0035
569 CONTRAINDICATED PRODUCT ADMINISTERED 105 0.0035
570 ACUTE MYOCARDIAL INFARCTION 102 0.0035
571 HEPATIC ENZYME INCREASED 235 0.0034
572 DECUBITUS ULCER 28 0.0034
573 MOTOR DYSFUNCTION 35 0.0034
574 GASTRITIS EROSIVE 16 0.0034
575 URINE OUTPUT DECREASED 30 0.0034
576 PREMATURE BABY 103 0.0034
577 DERMATITIS ALLERGIC 43 0.0034
578 STREPTOCOCCAL INFECTION 19 0.0034
579 BLOOD UREA INCREASED 57 0.0034
580 LIVER FUNCTION TEST INCREASED 73 0.0034
581 VENTRICULAR TACHYCARDIA 56 0.0034
582 HYPOKINESIA 49 0.0034
583 JOINT EFFUSION 23 0.0033
584 ALTERED STATE OF CONSCIOUSNESS 72 0.0033
585 PANCREATITIS ACUTE 74 0.0033
586 OXYGEN SATURATION DECREASED 184 0.0033
587 CHOLECYSTITIS 39 0.0033
588 ATRIAL FLUTTER 26 0.0033
589 POSTOPERATIVE WOUND INFECTION 22 0.0033
590 NASAL POLYPS 16 0.0032
591 SECOND PRIMARY MALIGNANCY 27 0.0032
592 FUNGAL INFECTION 108 0.0032
593 DEPRESSED LEVEL OF CONSCIOUSNESS 128 0.0032
594 ELECTROCARDIOGRAM ABNORMAL 25 0.0032
595 CARDIOMEGALY 39 0.0032
596 EXTRAPYRAMIDAL DISORDER 78 0.0031
597 PROTEINURIA 59 0.0031
598 CARDIAC FAILURE 248 0.0031
599 INTERNATIONAL NORMALISED RATIO INCREASED 88 0.0031
600 FOETAL DEATH 16 0.0031
601 PNEUMONIA 998 0.0031
602 PERIORBITAL OEDEMA 16 0.0031
603 RENAL FAILURE 409 0.0031
604 HAEMORRHOIDS 60 0.0031
605 RESPIRATORY TRACT INFECTION 80 0.0031
606 RENAL FAILURE ACUTE 130 0.0031
607 NEUROLEPTIC MALIGNANT SYNDROME 36 0.0030
608 SKIN INFECTION 34 0.0030
609 OFF LABEL USE 2647 0.0030
610 ANAEMIA 575 0.0030
611 VASCULITIS 35 0.0030
612 LUNG DISORDER 147 0.0030
613 HYPONATRAEMIA 168 0.0030
614 GENERAL PHYSICAL HEALTH DETERIORATION 344 0.0030
615 VENTRICULAR FIBRILLATION 33 0.0030
616 FOETAL GROWTH RESTRICTION 18 0.0030
617 MOUTH SWELLING 17 0.0029
618 WHITE BLOOD CELL COUNT INCREASED 113 0.0029
619 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 16 0.0029
620 STRESS CARDIOMYOPATHY 17 0.0029
621 TREATMENT FAILURE 242 0.0029
622 LARYNGEAL OEDEMA 18 0.0029
623 HYPERTRIGLYCERIDAEMIA 17 0.0029
624 RENAL CYST 23 0.0029
625 BRONCHOSPASM 41 0.0029
626 ARTERIOSCLEROSIS CORONARY ARTERY 19 0.0029
627 MENINGITIS 19 0.0028
628 POLYNEUROPATHY 34 0.0028
629 LEFT VENTRICULAR DYSFUNCTION 19 0.0028
630 CHILLS 332 0.0028
631 SUPRAVENTRICULAR TACHYCARDIA 27 0.0028
632 VITAMIN D DEFICIENCY 27 0.0028
633 MUSCLE RIGIDITY 33 0.0028
634 DISEASE PROGRESSION 326 0.0028
635 HYPOGLYCAEMIA 133 0.0027
636 GASTRIC ULCER 52 0.0027
637 LIVER DISORDER 121 0.0027
638 HALLUCINATION, VISUAL 57 0.0027
639 CYANOSIS 42 0.0027
640 PERICARDIAL EFFUSION 61 0.0026
641 SPUTUM DISCOLOURED 25 0.0026
642 TROPONIN INCREASED 20 0.0026
643 THERAPY PARTIAL RESPONDER 41 0.0026
644 ECCHYMOSIS 18 0.0026
645 COMA 125 0.0026
646 GLOMERULAR FILTRATION RATE DECREASED 32 0.0026
647 LOWER RESPIRATORY TRACT INFECTION 118 0.0026
648 EYELID OEDEMA 30 0.0026
649 PRODUCT USE IN UNAPPROVED INDICATION 630 0.0025
650 ACUTE CORONARY SYNDROME 21 0.0025
651 PULMONARY OEDEMA 113 0.0025
652 EPILEPSY 76 0.0025
653 SINUS BRADYCARDIA 24 0.0025
654 HYPOAESTHESIA ORAL 37 0.0025
655 CARDIO-RESPIRATORY ARREST 101 0.0024
656 EMBOLISM 20 0.0024
657 VENTRICULAR EXTRASYSTOLES 25 0.0024
658 SKIN LESION 66 0.0024
659 GASTROINTESTINAL HAEMORRHAGE 201 0.0024
660 TENDERNESS 25 0.0024
661 HYPERGLYCAEMIA 87 0.0024
662 BLISTER 134 0.0024
663 LYMPHADENOPATHY 84 0.0024
664 BLOOD DISORDER 19 0.0024
665 HAEMOGLOBIN DECREASED 243 0.0024
666 HYPERCALCAEMIA 29 0.0023
667 FLANK PAIN 22 0.0023
668 GASTROENTERITIS 34 0.0023
669 OSTEOMYELITIS 42 0.0023
670 MOUTH HAEMORRHAGE 17 0.0023
671 LYMPHOEDEMA 16 0.0023
672 DRUG INEFFECTIVE 3045 0.0023
673 MENTAL STATUS CHANGES 64 0.0023
674 INFECTION 333 0.0023
675 GASTROINTESTINAL INFLAMMATION 18 0.0023
676 RIGHT VENTRICULAR FAILURE 16 0.0023
677 NEOPLASM PROGRESSION 78 0.0022
678 HAEMATOMA 58 0.0022
679 ANGIOEDEMA 99 0.0022
680 COVID-19 392 0.0022
681 ARTERIOSCLEROSIS 21 0.0022
682 FAECES DISCOLOURED 48 0.0022
683 MATERNAL EXPOSURE DURING PREGNANCY 197 0.0022
684 DIFFUSE LARGE B-CELL LYMPHOMA 17 0.0022
685 ABDOMINAL PAIN 513 0.0022
686 HYPOTONIA 22 0.0022
687 MYOCARDITIS 25 0.0022
688 CEREBRAL HAEMORRHAGE 78 0.0022
689 NERVOUS SYSTEM DISORDER 68 0.0022
690 OVARIAN CANCER 20 0.0022
691 PSYCHOTIC DISORDER 64 0.0022
692 NERVE COMPRESSION 20 0.0022
693 ATRIAL FIBRILLATION 210 0.0022
694 FISTULA 24 0.0021
695 UNRESPONSIVE TO STIMULI 55 0.0021
696 OEDEMA 115 0.0021
697 FACIAL PARALYSIS 18 0.0021
698 BRADYCARDIA 111 0.0021
699 MOUTH ULCERATION 44 0.0021
700 CHROMATURIA 47 0.0021
701 HAEMORRHAGE INTRACRANIAL 31 0.0021
702 ISCHAEMIC STROKE 37 0.0021
703 RESPIRATORY ARREST 57 0.0021
704 PANCREATITIS 109 0.0021
705 SKIN REACTION 29 0.0021
706 PULMONARY CONGESTION 27 0.0020
707 VISUAL ACUITY REDUCED 68 0.0020
708 INFLAMMATION 105 0.0020
709 LIVE BIRTH 17 0.0020
710 DIVERTICULITIS 56 0.0020
711 SEIZURE 233 0.0020
712 PULMONARY MASS 30 0.0020
713 ASPIRATION 22 0.0020
714 NEOPLASM 23 0.0020
715 INTERVERTEBRAL DISC PROTRUSION 43 0.0020
716 EAR PAIN 38 0.0020
717 RESPIRATORY SYNCYTIAL VIRUS INFECTION 17 0.0020
718 RASH 845 0.0019
719 PRODUCT PRESCRIBING ISSUE 42 0.0019
720 HAEMATOCRIT DECREASED 38 0.0019
721 ORAL HERPES 37 0.0019
722 MUSCLE ATROPHY 24 0.0019
723 HEMIPARESIS 32 0.0019
724 PULMONARY FIBROSIS 36 0.0019
725 RESPIRATORY DISORDER 56 0.0019
726 MYELODYSPLASTIC SYNDROME 27 0.0019
727 INJECTION SITE EXTRAVASATION 23 0.0019
728 WHITE BLOOD CELL COUNT DECREASED 202 0.0019
729 CONFUSIONAL STATE 298 0.0018
730 GRIP STRENGTH DECREASED 16 0.0018
731 RASH MACULAR 63 0.0018
732 CEREBRAL INFARCTION 44 0.0018
733 TOXICITY TO VARIOUS AGENTS 302 0.0018
734 MYOSITIS 16 0.0018
735 LOCALISED INFECTION 43 0.0018
736 ATAXIA 21 0.0018
737 RECTAL HAEMORRHAGE 76 0.0018
738 INFUSION RELATED REACTION 117 0.0018
739 DIALYSIS 25 0.0018
740 SECRETION DISCHARGE 22 0.0018
741 SUBDURAL HAEMATOMA 25 0.0017
742 BLOOD PRESSURE SYSTOLIC INCREASED 34 0.0017
743 NEUROPATHY PERIPHERAL 165 0.0017
744 CONJUNCTIVITIS 32 0.0017
745 DIARRHOEA HAEMORRHAGIC 16 0.0017
746 DIARRHOEA 1102 0.0017
747 BLOOD CALCIUM DECREASED 19 0.0017
748 HAEMATOTOXICITY 16 0.0017
749 RASH PRURITIC 90 0.0017
750 DYSURIA 61 0.0017
751 SKIN LACERATION 18 0.0017
752 ANGINA PECTORIS 47 0.0016
753 AGITATION 119 0.0016
754 ERYTHEMA 330 0.0016
755 BLOOD IRON DECREASED 19 0.0016
756 EMPHYSEMA 16 0.0016
757 RESTLESSNESS 58 0.0016
758 PRODUCT ADMINISTRATION ERROR 32 0.0016
759 DYSPHAGIA 150 0.0016
760 FOETAL EXPOSURE DURING PREGNANCY 128 0.0016
761 PULMONARY EMBOLISM 149 0.0016
762 BLOOD CREATINE PHOSPHOKINASE INCREASED 45 0.0016
763 ORAL PAIN 35 0.0016
764 BLOOD POTASSIUM DECREASED 47 0.0016
765 GASTRITIS 41 0.0016
766 LETHARGY 89 0.0015
767 SMALL INTESTINAL OBSTRUCTION 19 0.0015
768 HALLUCINATION 116 0.0015
769 HAEMATEMESIS 39 0.0015
770 URINARY TRACT INFECTION 259 0.0015
771 STOMATITIS 91 0.0015
772 PRODUCTIVE COUGH 71 0.0015
773 DISEASE RECURRENCE 70 0.0015
774 HYPERSENSITIVITY 273 0.0015
775 EXPOSURE DURING PREGNANCY 91 0.0015
776 ARRHYTHMIA 69 0.0015
777 WHEEZING 86 0.0014
778 EPISTAXIS 108 0.0014
779 PERICARDITIS 24 0.0014
780 DYSPNOEA 807 0.0014
781 VOMITING 666 0.0014
782 DYSARTHRIA 53 0.0014
783 THERAPEUTIC PRODUCT EFFECT DECREASED 63 0.0014
784 PULMONARY HYPERTENSION 29 0.0014
785 GASTRIC HAEMORRHAGE 16 0.0014
786 ABDOMINAL PAIN LOWER 35 0.0014
787 DERMATITIS 29 0.0014
788 HEPATIC CIRRHOSIS 26 0.0014
789 NODULE 18 0.0014
790 PRODUCT USE ISSUE 255 0.0014
791 RENAL INJURY 40 0.0013
792 BLOOD PRESSURE DECREASED 89 0.0013
793 TASTE DISORDER 27 0.0013
794 HYPOPHAGIA 34 0.0013
795 OEDEMA PERIPHERAL 162 0.0013
796 INTESTINAL OBSTRUCTION 50 0.0013
797 LIP SWELLING 44 0.0013
798 APHASIA 39 0.0013
799 URINARY RETENTION 43 0.0013
800 DISORIENTATION 51 0.0013
801 IMMUNODEFICIENCY 19 0.0013
802 PHOTOSENSITIVITY REACTION 21 0.0013
803 PAIN IN JAW 36 0.0013
804 HERPES ZOSTER 73 0.0013
805 INCREASED APPETITE 24 0.0013
806 PALLOR 34 0.0012
807 HYPERTENSION 263 0.0012
808 MALIGNANT NEOPLASM PROGRESSION 127 0.0012
809 UPPER RESPIRATORY TRACT INFECTION 57 0.0012
810 INTENTIONAL PRODUCT USE ISSUE 108 0.0012
811 FEEDING DISORDER 25 0.0012
812 ECZEMA 64 0.0012
813 DRUG INTOLERANCE 118 0.0012
814 BLOOD URINE PRESENT 23 0.0012
815 END STAGE RENAL DISEASE 22 0.0012
816 RASH PAPULAR 27 0.0012
817 SKIN EXFOLIATION 100 0.0012
818 COUGH 331 0.0012
819 ABDOMINAL DISTENSION 123 0.0012
820 DEEP VEIN THROMBOSIS 76 0.0012
821 SKIN DISORDER 39 0.0012
822 FLUID OVERLOAD 17 0.0012
823 LUNG INFECTION 18 0.0012
824 RED BLOOD CELL COUNT DECREASED 33 0.0012
825 PROCEDURAL PAIN 32 0.0012
826 EYE PAIN 65 0.0012
827 PRESYNCOPE 28 0.0012
828 CARDIOMYOPATHY 17 0.0011
829 GASTROINTESTINAL DISORDER 103 0.0011
830 DECREASED APPETITE 267 0.0011
831 PSYCHOMOTOR HYPERACTIVITY 19 0.0011
832 HAEMATOCHEZIA 62 0.0011
833 PRURITUS 428 0.0011
834 CARDIAC FAILURE CONGESTIVE 89 0.0011
835 LYMPHOMA 17 0.0011
836 CHEST DISCOMFORT 112 0.0011
837 CHEST PAIN 202 0.0011
838 DYSPEPSIA 107 0.0011
839 FEELING COLD 30 0.0011
840 SINUS DISORDER 21 0.0011
841 NIGHT SWEATS 34 0.0011
842 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 74 0.0010
843 HEART RATE INCREASED 101 0.0010
844 RASH GENERALISED 26 0.0010
845 BLOOD POTASSIUM INCREASED 16 0.0010
846 SWELLING FACE 64 0.0010
847 TYPE 2 DIABETES MELLITUS 33 0.0010
848 PRODUCT PRESCRIBING ERROR 23 0.0010
849 BACK PAIN 223 0.0010
850 BRONCHITIS 71 0.0010
851 INFLUENZA 106 0.0009
852 DEHYDRATION 126 0.0009
853 MUSCULAR WEAKNESS 107 0.0009
854 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
855 SWOLLEN TONGUE 29 0.0009
856 HAEMORRHAGE 97 0.0009
857 CYSTITIS 29 0.0009
858 BLOOD PRESSURE ABNORMAL 18 0.0009
859 CONSTIPATION 197 0.0009
860 NAUSEA 713 0.0009
861 PLASMA CELL MYELOMA 35 0.0009
862 OROPHARYNGEAL PAIN 83 0.0009
863 CORONARY ARTERY DISEASE 27 0.0009
864 SKIN ULCER 23 0.0009
865 JOINT INJURY 19 0.0009
866 MALAISE 388 0.0009
867 URTICARIA 148 0.0009
868 HYPOACUSIS 38 0.0009
869 THROMBOSIS 71 0.0009
870 NEURALGIA 21 0.0009
871 ASTHENIA 323 0.0009
872 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
873 PHOTOPHOBIA 16 0.0008
874 SNEEZING 19 0.0008
875 HYPERHIDROSIS 109 0.0008
876 DEAFNESS 22 0.0008
877 MUSCULOSKELETAL DISORDER 16 0.0008
878 RHINORRHOEA 54 0.0008
879 NEPHROLITHIASIS 38 0.0008
880 OSTEOARTHRITIS 35 0.0008
881 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 43 0.0008
882 SYNCOPE 82 0.0008
883 KIDNEY INFECTION 16 0.0008
884 LOSS OF CONSCIOUSNESS 104 0.0008
885 INTENTIONAL PRODUCT MISUSE 71 0.0008
886 MOVEMENT DISORDER 26 0.0008
887 CHRONIC KIDNEY DISEASE 61 0.0008
888 ABORTION SPONTANEOUS 32 0.0008
889 ACCIDENTAL OVERDOSE 29 0.0008
890 DIABETIC KETOACIDOSIS 19 0.0008
891 CARDIOVASCULAR DISORDER 20 0.0008
892 OVERDOSE 166 0.0008
893 TREMOR 127 0.0008
894 FLUSHING 77 0.0008
895 SPEECH DISORDER 39 0.0007
896 WEIGHT DECREASED 207 0.0007
897 MEDICATION ERROR 41 0.0007
898 LABORATORY TEST ABNORMAL 21 0.0007
899 THERAPEUTIC RESPONSE DECREASED 43 0.0007
900 LIMB INJURY 19 0.0007
901 EYE SWELLING 26 0.0007
902 DYSPHONIA 40 0.0007
903 TREATMENT NONCOMPLIANCE 37 0.0007
904 GASTROOESOPHAGEAL REFLUX DISEASE 54 0.0007
905 RENAL DISORDER 31 0.0007
906 COLITIS ULCERATIVE 29 0.0006
907 ABDOMINAL PAIN UPPER 132 0.0006
908 BLOOD PRESSURE INCREASED 98 0.0006
909 CHOLELITHIASIS 21 0.0006
910 ALOPECIA 125 0.0006
911 POLLAKIURIA 26 0.0006
912 ABDOMINAL DISCOMFORT 103 0.0006
913 NECK PAIN 34 0.0006
914 HYPOAESTHESIA 90 0.0006
915 SOMNOLENCE 121 0.0006
916 INFLUENZA LIKE ILLNESS 49 0.0006
917 SINUSITIS 61 0.0006
918 HYPOTHYROIDISM 19 0.0006
919 PARAESTHESIA 92 0.0006
920 MENTAL DISORDER 25 0.0006
921 WOUND 16 0.0006
922 ARTHRALGIA 238 0.0006
923 PALPITATIONS 67 0.0006
924 JOINT SWELLING 68 0.0006
925 PAIN 346 0.0006
926 DYSPNOEA EXERTIONAL 21 0.0006
927 FATIGUE 424 0.0005
928 DISTURBANCE IN ATTENTION 29 0.0005
929 BURNING SENSATION 37 0.0005
930 DIABETES MELLITUS 40 0.0005
931 PANIC ATTACK 19 0.0005
932 FLUID RETENTION 26 0.0005
933 WEIGHT INCREASED 113 0.0005
934 RHEUMATOID ARTHRITIS 57 0.0005
935 MOOD SWINGS 16 0.0005
936 NASAL CONGESTION 29 0.0005
937 COGNITIVE DISORDER 23 0.0005
938 OSTEONECROSIS 16 0.0005
939 INCORRECT DOSE ADMINISTERED 110 0.0005
940 SLEEP DISORDER 34 0.0005
941 MUSCULOSKELETAL STIFFNESS 42 0.0005
942 MYALGIA 80 0.0005
943 INJURY 33 0.0005
944 THROAT IRRITATION 21 0.0005
945 DEATH 399 0.0005
946 GAIT DISTURBANCE 87 0.0005
947 INTENTIONAL OVERDOSE 29 0.0005
948 DRUG WITHDRAWAL SYNDROME 39 0.0004
949 PERIPHERAL SWELLING 68 0.0004
950 VISUAL IMPAIRMENT 53 0.0004
951 AGGRESSION 21 0.0004
952 BALANCE DISORDER 36 0.0004
953 UNEVALUABLE EVENT 31 0.0004
954 FALL 134 0.0004
955 DRY MOUTH 32 0.0004
956 SKIN DISCOLOURATION 18 0.0004
957 HEADACHE 245 0.0004
958 DYSGEUSIA 29 0.0004
959 PAIN IN EXTREMITY 115 0.0004
960 MYOCARDIAL INFARCTION 65 0.0004
961 CEREBROVASCULAR ACCIDENT 62 0.0004
962 OCULAR HYPERAEMIA 17 0.0004
963 CONVULSION 20 0.0003
964 ILLNESS 36 0.0003
965 SWELLING 32 0.0003
966 DEPRESSION 76 0.0003
967 ASTHMA 36 0.0003
968 MUSCLE SPASMS 58 0.0003
969 HOSPITALISATION 48 0.0003
970 DISCOMFORT 19 0.0003
971 FEELING HOT 19 0.0003
972 HOT FLUSH 23 0.0003
973 DIZZINESS 148 0.0003
974 NO ADVERSE EVENT 53 0.0003
975 BONE PAIN 17 0.0003
976 FLATULENCE 16 0.0003
977 MOBILITY DECREASED 20 0.0003
978 ADVERSE DRUG REACTION 25 0.0003
979 NASOPHARYNGITIS 50 0.0003
980 EMOTIONAL DISTRESS 32 0.0003
981 VERTIGO 16 0.0003
982 CONTUSION 24 0.0002
983 MIGRAINE 22 0.0002
984 ANXIETY 65 0.0002
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
986 UNDERDOSE 16 0.0002
987 BLOOD GLUCOSE INCREASED 39 0.0002
988 DRY SKIN 26 0.0002
989 DRUG ABUSE 16 0.0002
990 VISION BLURRED 26 0.0002
991 INSOMNIA 47 0.0002
992 DRUG DEPENDENCE 23 0.0001
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
994 PRODUCT DOSE OMISSION ISSUE 36 0.0001
995 INJECTION SITE PAIN 24 0.0001
996 FEELING ABNORMAL 17 0.0001